Generics 121

Originals 2

Biosimilars

Medical devices

Nutraceuticals 1

Filters

Ursodeoxycholic acid manufacturers

121 products found

Filters

121 products found

ursodeoxycholic acid

Capsules 150 mg, 300 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Honduras , Nicaragua , Panama
Comments
Differentiated strength 500 mg
Manufacturer #17633
In the 1950s, the pharmaceutical laboratory was established. Its first manufacturing facility for inhalation aerosols was established in the 1960s, making it one of the first companies to introduce such a product to the market. It was one of the first firms in the world to sell silver sulfadiazine as a pharmaceutical product in cream and aerosol form.

Manufacturer usually replies in 9 days

ursodeoxycholic acid

Capsules 250mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Australia , Azerbaijan , Bahrain , Belgium , Chile , Czech Republic , Denmark , Estonia , Finland , Kazakhstan , Kuwait , Latvia , Lithuania , Netherlands , New Zealand , Norway , Oman , Poland , Portugal , Qatar , Saudi Arabia , Singapore , Sweden , United Arab Emirates , United Kingdom , Vietnam
Available for
Distribution only
Manufacturer #1250

Manufacturer usually replies in 6 days

ursodeoxycholic acid

Tablets, prolonged release (PR) 450 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Technology transfer
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

ursodeoxycholic acid

Capsules 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

ursodeoxycholic acid

Capsules 150mg, 300mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Hungary , Ireland , Italy , Latvia , Lithuania , Luxembourg , Malta , Netherlands , Poland , Portugal , Romania , Slovenia , Slovakia , Spain , Sweden , United Kingdom
Manufacturer #570
A pharmaceutical manufacturer based in the EU that has been active in 80+ countries selling its products for 110+ years. Main therapeutic areas include CNS, respiratory, and women’s health. Main dosage forms include sterile drugs, solid oral, and liquid forms. The company owns 20+ branches in Europe, North America, and Asia. The company possesses manufacturing facilities in Europe, Asia, and LATAM.

Manufacturer usually replies in 8 days

ursodeoxycholic acid

Tablets 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 5 days

ursodeoxycholic acid

Capsules 300mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #457

Manufacturer usually replies in 2 days

ursodeoxycholic acid

Capsules 150mg, 250mg, 300mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 4 days

ursodeoxycholic acid

Oral suspension 250mg/5ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
Manufacturer #554

Manufacturer usually replies in 4 days

ursodeoxycholic acid

Capsules 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
BE study carried on vs the EU reference.
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 5 days

ursodeoxycholic acid

Tablets 300 mg, 450 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 5 days

ursodeoxycholic acid

Oral suspension 250 mg/ml - 250 ml bottle

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #610
A pharmaceutical manufacturer based in the EU that is active in 20+ countries selling its products in EU, Middle East, LATAM, CIS, and Asia for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. Main therapeutic areas include CNS, antibiotics, and the cardiovascular system.

Manufacturer usually replies in 5 days

ursodeoxycholic acid

Tablets, film coated 500mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10033
A pharmaceutical manufacturer based in Europe specializes in development and manufacturing for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. The main therapy areas include the immune system, CNS, and cardiovascular system. The main dosage forms include solid oral and injectable.

Manufacturer usually replies in 11 days

ursodeoxycholic acid

Capsules 150 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29019

Manufacturer usually replies in nan days

ursodeoxycholic acid

Tablets, film coated 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #29019

Manufacturer usually replies in nan days

ursodeoxycholic acid

Tablets, film coated 250 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Bosnia And Herzegovina
GMP approvals
EU GMP
Comments
Documentation is ready for a bibliographic type of application thus BE studies are not available
Manufacturer #21530

Manufacturer usually replies in 4 days

ursodeoxycholic acid

Tablets 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
BE studies are not available
Manufacturer #21496

It's a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 9 days

ursodeoxycholic acid

Tablets, film coated 150 mg, 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #22627

Manufacturer usually replies in 4 days

ursodeoxycholic acid

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Unavailable markets
India
Manufacturer #18850

Manufacturer usually replies in 2 days

ursodeoxycholic acid

Tablets, film coated 250 mg, 500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
Ukraine
GMP approvals
EU GMP
Comments
Dossier availability date: Q2 2024
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

Want to view all 121 products? Create your free account today!

Ursodeoxycholic acid is a bile acid used to treat gallstones as well as to treat and prevent the progression of cystic fibrosis-related liver disorders. Suppliers of ursodeoxycholic acid market it in the form of 150mg, 250mg and 500mg oral tablets and capsules. The market for ursodeoxycholic acid is relatively competitive, populated with numerous manufacturing companies and suppliers. The largest manufacturers of ursodeoxycholic acid market globally are companies Mitsubishi Tanabe Pharma, Daewoong Chemical, and PharmaZell, Glenmark Pharmaceuticals, Dipharma Francis, Errengierre, and Grindeks. Ursodeoxycholic acid suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified ursodeoxycholic acid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 50 (250mg) tablets of ursodeoxycholic acid fall into an approximate range of 12,00 EUR to 15,00 EUR, whereas the equivalent amount of 500mg tablets cost from 25,00 EUR to 30,00 EUR.